These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2002597)

  • 1. [Calcium antagonists in cardiomyopathy].
    Takabatake Y
    Nihon Rinsho; 1991 Jan; 49(1):168-75. PubMed ID: 2002597
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blocking agents in congestive heart failure.
    Baughman KL
    Am J Med; 1986 Feb; 80(2B):46-50. PubMed ID: 3511695
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium antagonists in cardiomyopathy.
    Richardson PJ
    Br J Clin Pract Suppl; 1988 Apr; 60():33-7. PubMed ID: 3151269
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of cardiomyopathy using Ca blockers].
    Matsumori A; Tominaga M; Kawai C
    Nihon Rinsho; 1989 Aug; 47(8):1825-30. PubMed ID: 2585747
    [No Abstract]   [Full Text] [Related]  

  • 6. [Calcium antagonists and heart failure. Critical review of the literature].
    Devigili G
    Minerva Cardioangiol; 1994 Apr; 42(4):177-89. PubMed ID: 8058185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of diltiazem on regional left ventricular diastolic filling dynamics in patients with hypertrophic cardiomyopathy as assessed by color kinesis.
    Ito T; Suwa M; Imai M; Hozumi T; Tonari S; Kitaura Y
    Circ J; 2004 Nov; 68(11):1035-40. PubMed ID: 15502385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persisting effect of Ca(2+)-channel blockers on left ventricular function in hypertrophic cardiomyopathy after 14 years' treatment.
    Hartmann A; Schnell J; Hopf R; Kneissl G
    Angiology; 1996 Aug; 47(8):765-73. PubMed ID: 8712479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical use of calcium channel blockers.
    Mayer WP
    Alaska Med; 1984; 26(1):10-2. PubMed ID: 6539573
    [No Abstract]   [Full Text] [Related]  

  • 10. Common with the uncommon--atrial septal defect with hypertrophic cardiomyopathy.
    Matta R; Nair SK; Balakrishnan KG
    Indian Heart J; 1995; 47(4):372-4. PubMed ID: 8557282
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of intracoronary nicardipine, diltiazem and verapamil on coronary blood flow.
    Fugit MD; Rubal BJ; Donovan DJ
    J Invasive Cardiol; 2000 Feb; 12(2):80-5. PubMed ID: 10731269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Countermeasure for severe acute cardiomyopathies].
    Nakano T; Yamakado T
    Nihon Naika Gakkai Zasshi; 1993 Feb; 82(2):235-9. PubMed ID: 8098351
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic window for calcium-channel blockers in the management of dilated cardiomyopathy: a prospective, two-centre study on non-advanced disease.
    Wojnicz R; Nowak J; Lekston A; Wilczewski P; Nowalany-Kozielska E; Streb W; Wojciechowska C; Stolarz W; Helewski K; Szyguła-Jurkiewicz B; Poloński L
    Cardiology; 2010; 117(2):148-54. PubMed ID: 20975267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Verapamil, diltiazem or nifedipine in severe left ventricular functional disorder? A comparative study of the immediate hemodynamic effects].
    Figulla HR; Kreuzer H; Luig H
    Dtsch Med Wochenschr; 1986 Jan; 111(1):11-4. PubMed ID: 3940829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertensive hypertrophic cardiomyopathy of the elderly.
    Topol EJ; Traill TA; Fortuin NJ
    N Engl J Med; 1985 Jan; 312(5):277-83. PubMed ID: 2857050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diltiazem treatment prevents diastolic heart failure in mice with familial hypertrophic cardiomyopathy.
    Westermann D; Knollmann BC; Steendijk P; Rutschow S; Riad A; Pauschinger M; Potter JD; Schultheiss HP; Tschöpe C
    Eur J Heart Fail; 2006 Mar; 8(2):115-21. PubMed ID: 16214409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of calcium channel blockers in hypertrophic cardiomyopathy.
    Lorell BH
    Am J Med; 1985 Feb; 78(2B):43-54. PubMed ID: 4038850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calcium antagonists in cardiology].
    Tullio D; Valerio A; D'Agostino F
    Clin Ter; 1983 Jan; 104(1):27-51. PubMed ID: 6337771
    [No Abstract]   [Full Text] [Related]  

  • 19. [Calcium antagonists in congestive heart failure].
    Barbieri L; Mestroni L; Camerini F
    G Ital Cardiol; 1988 Nov; 18(11):989-96. PubMed ID: 3073994
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to isoproterenol as a prognostic indicator of evolution from hypertrophic cardiomyopathy to a phase resembling dilated cardiomyopathy.
    Kawano S; Iida K; Fujieda K; Yukisada K; Magdi ES; Iwasaki Y; Tabei F; Yamaguchi I; Sugishita Y
    J Am Coll Cardiol; 1995 Mar; 25(3):687-92. PubMed ID: 7860914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.